CEGID GROUP: simplified public purchase offer initiated by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
149
CEGID GROUP: simplified public purchase offer initiated by Claudius France

PRESS RELEASE  

Claudius France

Registered office: 33, rue de Naples, 75008 Paris 821 096 039 RCS Paris

SIMPLIFIED PUBLIC PURCHASE OFFER

 ON THE SHARES AND REDEEMABLE SHARE WARRANTS OF CEGID GROUP

OFFER PRICE

86.25 euros per share Cegid Group

68.25 euros per redeemable share warrant Cegid Group

If, upon completion of the Offer, the minority shareholders not having tendered their shares into the Offer do not represent more than 5% of the share capital or of the voting rights of the Company, Claudius France will request the implementation of a squeeze-out, in accordance with the provisions of Articles 237-14 to 237-19 of the AMF General Regulation

This press release was prepared and published by Claudius France, société par actions simplifiée unipersonnelle , whose registered office is located 33, rue de Naples, 75008 Paris and registered with the Paris Trade and Companies Register under number 821 096 039 (" Claudius France "), in accordance with the provisions of Articles 231-27 2° and 231-28 of the General Regulation of the Autorité des Marchés Financiers (the " AMF ").

IMPORTANT NOTICE

Pursuant to Article L. 433-4 III of the French Monetary and Financial Code and Articles 237-14 et seq. of the General Regulation ( Règlement Général ) of the Autorité des marchés financiers , in the event that, upon closing of the Offer, the shareholders not having tendered their securities to the Offer do not represent more than 5% of the share capital or voting rights of Cegid Group, Claudius France will request the implementation of a squeeze-out ( retrait obligatoire ), it being specified that as a result of such procedure, Cegid Group shares and redeemable share warrants would be delisted.

Paris, France, July 4, 2017 - Pursuant to the provisions of Article L. 612-8 of the French Monetary and Financial Code and of Article 231-23 of the AMF General Regulation, the AMF granted visa n° 17-322 on the simplified public purchase offer by which Claudius France irrevocably undertakes to purchase, in cash, (i) all shares of Cegid Group at a price of 86.25 euros per share and (ii) all redeemable share warrants (the " BAAR ") of Cegid Group at a price of 68.25 euros per BAAR (the " Offer ").

The offer document (the " Offer Document ") prepared by Claudius France was granted visa by the AMF on July 4, 2017 under n° 17-322, pursuant to a clearance decision issued on the same date.

Prior to the opening of the Offer, the AMF and Euronext Paris will respectively publish a notice announcing the opening and closing dates and a notice announcing the terms and the timetable of the Offer.

The Offer shall be opened for a period of 10 trading days. The AMF will publish a notice announcing the opening date and the closing date of the Offer. The shareholders or holders of BAAR of the Company whose shares or BAAR are registered on an account managed by a financial intermediary and who wish to tender their shares or their BAAR into the Offer, must deliver a transfer order to their financial intermediary to tender their shares and BAAR into the Offer, in accordance with the standard forms provided by their financial intermediary no later than the last day on which the Offer is open and in a timely manner so that their order can be executed within the relevant timeframe. The shareholders and holders of BAAR of the Company should consult with their own financial intermediaries to confirm whether said intermediary requires the securities to be tendered at an earlier date.

The "other information" document relating in particular to the legal, financial and accounting characteristics of Claudius France (the " Other Information Document ") was filed with the AMF and will be made available to the public on July 5, 2017, pursuant to the provisions of Articles 231-27 and 231-28 of the AMF General Regulation.

The offer document which was granted visa by the AMF and the Other Information Document are available on the websites of the AMF (www.amf-france.org) and of Cegid Group (www.cegid.com) and may be obtained free of charge upon request to Natixis, 47, quai d'Austerlitz, 75013 Paris, France.

Important information

This press release has been prepared for information purposes only. Investors and shareholders based in France should read the documentation relating to the Tender Offer, since such documentation contains important information concerning Claudius France, Cegid Group and the Tender Offer. The Tender Offer is not made in any jurisdiction in which it would be restricted. The Tender Offer is made in the U.S. pursuant to Section 14(e) of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Regulation 14E thereunder, as a "Tier-I" tender offer under Rule 14d-1(c) of the Exchange Act, and otherwise in accordance with applicable French law. This press release must not be published, distributed or disseminated, directly or indirectly, to any jurisdiction where the distribution of this information would be subject to legal restrictions. The publication, distribution or dissemination of this press release in certain jurisdictions may be subject to legal or regulatory restrictions. Therefore, the persons located in the jurisdictions where this press release is published, distributed or disseminated must inquire on such restrictions and comply with them. Claudius France disclaims all liability regarding a potential breach of these restrictions by whoever.

This English translation is for the convenience of English-speaking readers. However, only the French text has legal value. Consequently, the translation may not be relied upon to sustain any legal claim, nor should it be used as the basis of any legal opinion. Claudius France expressly disclaims all liability for any inaccuracy herein.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...a517dda279

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 5

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading

Top 5 Most Recently Viewed Articles

Sanoma Corporation Boosts Shareholders with Recent Buyback

Updated Category News Views 173

Sanoma Corporation's Share Buyback Initiative Sanoma Corporation is actively demonstrating its commitment to enhancing shareholder value through a recent buyback of its own shares. This strategic move signals confidence in its operational health and future growth prospects, making it an exciting time for investors. Details of the Share Acquisition The share buyback...

Continue Reading
Geotab Strengthens Fleet Sustainability with New Tools

Updated Category News Views 70

Innovative Sustainability Solutions from Geotab In the ever-evolving landscape of fleet management, sustainability has become a critical focus, especially in the fight against climate change. Geotab Inc., a leader in connected transportation solutions, has taken a significant step forward by launching a comprehensive suite of sustainability tools designed to help...

Continue Reading
Southwest Airlines Surpasses Quarterly Earnings Expectations

Updated Category News Views 61

Southwest Airlines Achieves Impressive Q3 Growth Southwest Airlines Co (NYSE: LUV) has reported a remarkable increase in its operating revenue for the third quarter, rising by 5.3% year-over-year to reach a total of $6.870 billion. This figure surpassed market expectations, which were set at $6.735 billion, signaling a strong performance amidst industry challenges....

Continue Reading
Exploring the Growth of Blockchain in Healthcare to $90.52 Billion

Updated Category News Views 70

Blockchain Technology Transforming the Healthcare Market The global healthcare market for blockchain technology is set for remarkable growth, with forecasts showing an increase from USD 2.84 billion in 2023 to an impressive USD 90.52 billion by 2033. This substantial growth, which represents a Compound Annual Growth Rate (CAGR) of 41.37%, underscores the rising adoption...

Continue Reading
GeneCentric's Groundbreaking Insights on Bladder Cancer Treatment

Updated Category News Views 67

GeneCentric Therapeutics dropped a bombshell with its GARNER study on bladder cancer back in 2024. This wasn't just another research initiative; it was the biggest cohort focused on high-risk non-muscle invasive bladder cancer (HR-NMIBC), aiming to reshape how we understand and treat this tough nut. GARNER Study: A Game Changer? The GARNER study stood out as a monumental...

Continue Reading